| 2022-05-17 | Sale | Teva Pharmaceutical Industries Limited TEVA | Executive VP, Global R&D | 130,000 0.0115% | $8.22 | $1.07M | +5.24% | |
| 2022-03-04 | Sale | Teva Pharmaceutical Industries Limited TEVA | Executive VP, Global R&D | 33,579 0.003% | $7.45 | $250,220 | +19.03% | |
| 2022-02-28 | Sale | Teva Pharmaceutical Industries Limited TEVA | Executive VP, Global R&D | 15,180 0.0014% | $8.14 | $123,599 | +8.73% | |
| 2022-02-09 | Sale | Teva Pharmaceutical Industries Limited TEVA | Executive VP, Global R&D | 12,232 0.0011% | $9.06 | $110,824 | -2.78% | |
| 2021-08-10 | Sale | Teva Pharmaceutical Industries Limited TEVA | Executive VP, Global R&D | 101,720 0.0091% | $9.95 | $1.01M | -13.66% | |
| 2021-05-11 | Sale | Teva Pharmaceutical Industries Limited TEVA | Executive VP, Global R&D | 38,132 0.0034% | $10.22 | $389,659 | -10.83% | |
| 2021-03-04 | Sale | Teva Pharmaceutical Industries Limited TEVA | Executive VP, Global R&D | 19,030 0.0017% | $10.57 | $201,073 | -10.49% | |
| 2021-03-02 | Sale | Teva Pharmaceutical Industries Limited TEVA | Executive VP, Global R&D | 100,000 0.0092% | $10.82 | $1.08M | -11.65% | |
| 2021-03-01 | Sale | Teva Pharmaceutical Industries Limited TEVA | Executive VP, Global R&D | 21,824 0.002% | $10.83 | $236,371 | -12.91% | |
| 2021-02-16 | Sale | Teva Pharmaceutical Industries Limited TEVA | Executive VP, Global R&D | 4,196 0.0004% | $11.12 | $46,672 | -14.82% | |
| 2021-02-09 | Sale | Teva Pharmaceutical Industries Limited TEVA | Executive VP, Global R&D | 58,992 0.0053% | $12.69 | $748,874 | -23.97% | |
| 2020-03-17 | Sale | Teva Pharmaceutical Industries Limited TEVA | Executive VP, Global R&D | 1,028 <0.0001% | $7.16 | $7,364 | +44.07% | |
| 2020-02-14 | Sale | Teva Pharmaceutical Industries Limited TEVA | Executive VP, Global R&D | 22,944 0.0021% | $12.14 | $278,591 | -15.38% | |
| 2020-02-10 | Sale | Teva Pharmaceutical Industries Limited TEVA | Executive VP, Global R&D | 11,088 0.001% | $12.27 | $136,050 | -16.19% | |
| 2019-12-31 | Sale | Teva Pharmaceutical Industries Limited TEVA | Executive VP, Global R&D | 4,918 0.0005% | $9.92 | $48,792 | +3.67% | |
| 2019-12-02 | Sale | Teva Pharmaceutical Industries Limited TEVA | Executive VP, Global R&D | 8,620 0.0008% | $10.49 | $90,429 | -1.66% | |
| 2019-03-18 | Sale | Teva Pharmaceutical Industries Limited TEVA | Executive VP, Global R&D | 712 <0.0001% | $16.63 | $11,837 | -43.45% | |
| 2019-03-04 | Sale | Teva Pharmaceutical Industries Limited TEVA | Executive VP, Global R&D | 818 <0.0001% | $16.88 | $13,811 | -42.93% | |
| 2019-02-14 | Sale | Teva Pharmaceutical Industries Limited TEVA | Executive VP, Global R&D | 3,682 0.0003% | $17.67 | $65,057 | -44.68% | |
| 2019-01-02 | Sale | Teva Pharmaceutical Industries Limited TEVA | Executive VP, Global R&D | 3,286 0.0003% | $15.70 | $51,598 | -38.49% |